What is the appropriate management for a patient presenting with a headache?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Acute Headache

Begin by immediately ruling out life-threatening secondary causes through targeted history and examination for red flags, then classify as primary versus secondary headache, and treat accordingly with evidence-based pharmacotherapy tailored to headache type and severity. 1, 2

Initial Assessment: Red Flags Requiring Urgent Investigation

The cornerstone is identifying patients who need immediate neuroimaging or further workup versus those with benign primary headache 3, 4:

Red Flags Mandating Urgent Evaluation

  • Thunderclap onset (pain peaking within 1 second to 1 minute) - consider subarachnoid hemorrhage 1, 5
  • Abrupt onset of severe headache - highest risk feature 1
  • Rapidly increasing frequency of headaches 1
  • Headache awakening patient from sleep 1
  • Focal neurologic signs or symptoms 1
  • History of uncoordination 1
  • Marked change in headache pattern 1
  • Persistent headache following head trauma 1
  • Headache worsened by Valsalva maneuver 1
  • New onset in patient >40-50 years old 1, 5
  • Fever with neck stiffness (meningitis) 2, 6
  • Presence of meningism, witnessed loss of consciousness, or limited neck flexion on exam 5

Neuroimaging Indications

Obtain CT head immediately if any red flags present; neuroimaging is NOT warranted for patients with normal neurologic examination and typical primary headache features meeting strict diagnostic criteria. 1

  • Consider neuroimaging for unexplained abnormal neurologic findings 1
  • If CT negative but subarachnoid hemorrhage suspected, proceed to lumbar puncture 7, 6

Classification of Primary Headaches

Once secondary causes excluded, classify using International Headache Society criteria 1:

Migraine Diagnostic Features (Need ≥2 of following)

  • Unilateral location 1
  • Throbbing character 1
  • Moderate to severe intensity 1
  • Worsening with routine activity 1

PLUS ≥1 of:

  • Nausea and/or vomiting 1
  • Photophobia and phonophobia 1

Tension-Type Headache Features (Need ≥2 of following)

  • Pressing, tightening, or nonpulsatile character 1
  • Mild to moderate intensity 1
  • Bilateral location 1
  • No aggravation with routine activity 1
  • No nausea/vomiting and no photophobia/phonophobia together (may have one) 1

Cluster Headache Features

  • Severe unilateral orbital, supraorbital, or temporal pain lasting 15-180 minutes 1
  • Ipsilateral autonomic features: lacrimation, nasal congestion, rhinorrhea, facial sweating, ptosis, miosis, eyelid edema 1
  • Frequency of 1-8 attacks per day 1

Treatment Algorithm by Headache Type and Severity

Mild to Moderate Migraine (First-Line)

Start with NSAIDs as first-line therapy, administered as early as possible during the attack. 1, 2

  • Naproxen sodium 500-825 mg at onset, repeat every 2-6 hours as needed (max 1.5g/day) 2
  • Ibuprofen 400-800 mg 2
  • Aspirin 900-1000 mg 2
  • Combination: aspirin + acetaminophen + caffeine (particularly effective) 1, 2

Add antiemetic 20-30 minutes before NSAID for synergistic analgesia: 2

  • Metoclopramide 10 mg PO 2
  • Prochlorperazine 25 mg PO 2

Moderate to Severe Migraine (First-Line)

Triptans are first-line for moderate-to-severe attacks or when NSAIDs fail. 2

Oral triptans with strong evidence: 2

  • Sumatriptan 50-100 mg
  • Rizatriptan 10 mg
  • Naratriptan 2.5 mg
  • Zolmitriptan 2.5-5 mg

For rapid onset or when nausea/vomiting present: 2

  • Subcutaneous sumatriptan 6 mg - most effective route, 59% pain-free at 2 hours, onset within 15 minutes 2
  • Intranasal sumatriptan 5-20 mg 2

Severe Migraine Requiring Parenteral Therapy

For ED/urgent care presentation, use IV combination therapy as first-line. 2

Recommended IV "Migraine Cocktail": 2

  • Metoclopramide 10 mg IV (provides direct analgesia, not just antiemetic effect) 2
  • Ketorolac 30 mg IV (60 mg IM if <65 years, reduce dose if ≥65 or renal impairment) 2

Alternative IV options: 2

  • Prochlorperazine 10 mg IV (comparable efficacy to metoclopramide, fewer side effects than chlorpromazine) 2
  • Dihydroergotamine (DHE) IV - good evidence for efficacy and safety 2

Avoid in severe migraine: 1, 2

  • Opioids (meperidine, hydromorphone) - lead to dependency, rebound headaches, loss of efficacy 1, 2
  • Reserve opioids only when all other options contraindicated and abuse risk addressed 2

Status Migrainosus (>72 hours)

  • Consider corticosteroids (though limited evidence for routine acute use) 2, 7
  • IV DHE protocols 2
  • Admit for IV therapy if outpatient management fails 7

Critical Medication-Overuse Headache Prevention

Limit ALL acute headache medications to no more than 2 days per week (twice weekly) to prevent medication-overuse headache. 1, 2

  • Frequent use (>2 days/week) of NSAIDs, triptans, ergotamines, opioids, or analgesics causes rebound headaches 1, 2
  • If patient requires acute treatment >2 days/week, initiate preventive therapy 2

When Current Medication Stops Working

First try a different triptan - failure of one does not predict failure of others. 2

Escalation Algorithm:

  1. Ensure early administration - triptans most effective when taken while pain still mild 2
  2. Add fast-acting NSAID to prevent 48-hour recurrence (occurs in 40% of patients) 2
  3. Change route - try subcutaneous if oral fails, especially if rapid peak intensity or vomiting 2
  4. Rule out medication-overuse headache if using acute meds >2 days/week 2
  5. Initiate preventive therapy if headaches impair quality of life despite optimized acute treatment 2

Do NOT allow patients to increase frequency of acute medication use - this creates vicious cycle of medication-overuse headache. 2

Contraindications and Cautions

Triptans - Avoid in:

  • Ischemic heart disease or previous MI 2
  • Uncontrolled hypertension 2
  • Significant cardiovascular disease 2

NSAIDs - Avoid in:

  • Renal impairment (CrCl <30 mL/min) 2
  • Active GI bleeding 2
  • Aspirin/NSAID-induced asthma 2

Metoclopramide - Contraindicated in:

  • Pheochromocytoma 2
  • Seizure disorder 2
  • GI bleeding or obstruction 2

Prochlorperazine - Additional risks:

  • Tardive dyskinesia 2
  • Hypotension, tachycardia, arrhythmias 2
  • Contraindicated with CNS depression or adrenergic blockers 2

Disposition and Follow-Up

Refer all primary headache patients to Headache Center/neurology for long-term management - lack of referral results in high relapse rates and repeat ED visits. 7, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acute Headache Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acute headache in the emergency department.

Handbook of clinical neurology, 2010

Research

Subarachnoid Hemorrhage and Headache.

Current pain and headache reports, 2019

Research

The headache in the Emergency Department.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.